Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.

scientific article published on 12 June 2017

Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/EPI.13813
P698PubMed publication ID28605011

P50authorHelen LeonardQ77336525
Jenny DownsQ88047935
Kingsley WongQ50184891
P2093author name stringAnn M Bergin
Heather E Olson
Zhan Lim
P2860cites workEarly- and late-onset complications of the ketogenic diet for intractable epilepsy.Q51528042
Risk factors for urolithiasis in children on the ketogenic diet.Q51552471
Benefits of an all-liquid ketogenic diet.Q55038931
The Ketogenic Diet: One Decade LaterQ22305961
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardationQ24534159
Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsyQ28267579
The three stages of epilepsy in patients with CDKL5 mutationsQ28268280
The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathyQ28272644
Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndromeQ28274920
Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study GroupQ28295420
Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.Q33910551
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.Q34097099
Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot StudyQ34190415
A multicenter study of the efficacy of the ketogenic diet.Q34480837
The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 childrenQ34481820
The ketogenic diet: from molecular mechanisms to clinical effectsQ34500346
Ketogenic diet improves core symptoms of autism in BTBR miceQ34766019
The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trialQ34775862
There is variability in the attainment of developmental milestones in the CDKL5 disorder.Q35053870
Ketone bodies mediate antiseizure effects through mitochondrial permeability transitionQ35779437
Anticonvulsant mechanisms of the ketogenic dietQ36714459
Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1.Q39922592
The ketogenic diet in infants--Advantages of early use.Q40557213
A randomized controlled trial of the ketogenic diet in refractory childhood epilepsyQ40827463
Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutationsQ42722242
Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infantsQ43061486
CDKL5 is a brain MeCP2 target gene regulated by DNA methylationQ43138683
A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsyQ44147677
Detrimental effects of the ketogenic diet on cognitive function in ratsQ44719319
Ketogenic diet effects on cognition, mood, and psychosocial adjustment in childrenQ45422148
Efficacy and safety of the ketogenic diet in Chinese childrenQ46136641
Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trialQ47428484
The ketogenic diet increases mitochondrial uncoupling protein levels and activityQ47866548
Ketogenic diet improves sleep quality in children with therapy-resistant epilepsyQ48479645
Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorderQ48766875
P433issue8
P921main subjectCDKL5 deficiency disorderQ40739448
P304page(s)1415-1422
P577publication date2017-06-12
P1433published inEpilepsiaQ5382969
P1476titleUse of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients
P478volume58